Christine Ring sold $259K of Nurix Therapeutics, Inc. (NRIX) stock

Christine Ring, Chief Legal Officer of Nurix Therapeutics, Inc. (NRIX), sold 11,008 shares of NRIX stock worth $259K, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Jul 2, 2026.

NRIX has moved +6.0% since the trade date, from $23.97 to $25.41 (Sep 21, 2026 close).